ŷNEWSƹNEWS׷ʤ

ڹΩ⸦楻󥿡Ĺʡ縩ǴȯΨ61ܤ˾徺

ʡǴήԤʹ接60ܤγȴ⸦楻󥿡ְ㤤ʤۥȎƤáǾ(EneNEWS)

VIDEO: Cancer epidemic underway in Fukushima — Rates up 6,000% says head of cancer research center — This is definitely a holocaust everythings being swept under the rug — Very, very frightening my family members are brainwashed

ư衧ʡǴήԤʹ - 60ܤγȴ⸦楻󥿡Ĺϸ - ֤ϴְ㤤ʤۥȤǤ...Ƥä줿(夦βʧ줿) - ˡ˶...β²ϡǾƤ

Published: February 4th, 2015 at 9:56 am ETBy ENENews

2015ǯ249:56 ETENENewsˤ

Fukushima resident Chieko Shiina, supporter of the Fukushima Collaborative Clinic (translated by Carole Hisasue), Jan 24, 2015 (emphasis added):

ʡ߽̾ûҡʡ綦Ʊ˥åΥݡʥ롦ˤä줿ˡ2015ǯ124ʶĴϵԡˡ

At 8:00 — Already, 85 children have had surgeries for thyroid cancer, there are 112-113 children who are suspected of having cancer. When children get cancers it progresses very quickly. The former person in charge of health, Yamashita Shunichi, said it would be only a 1 in a million chance of children getting any kind of cancer because of radiation. But he was lying. Right now, its like 1 in 3,000 — its an epidemic

8ʬν - þΤˡ85ͤλҤɤãѤƤͭ뤳Ȥ112ͤ113ͤλҶޤҶãȯɤȤ˿®˿ʹԤ롣

ǽˤꡢ餫μδȯɤҶ϶Ϥ100ͤˣͤγΨǤȵô͡ӰϸäϱͤƤ˸ߡ3000ͤ1ͤΤ褦ʤΤ - ήԤ...

The head of the National Cancer Research Center estimated right now in Fukushima the rate of cancer has gone up 61 times. And yet the govt and also the hospitals related to the govt are saying this is not because of radiation How long does the govt think that well be silent about this? In light of this epidemic, my anger will never die down. And then to think about the parents of the small children – how worried they must be.

Ω⸦楻󥿡Ĺϡ˸ʡδ(ȯ)Ψ61ܤ˾徺Ƥ롢ȿꤹ롣ơޤܤܴϢ±ϡǽǤϤʤȸäƤ... 桹ϤλˤĤۤȡɤΤ餤ܤĹֹͤƤήԤͤСܤϷ褷ƾä뤳ȤϤޤ󡣤ơʻҶξƤˤĤƹͤ - ǡ餬ۤʤФʤʤȤ

At 12:00 — Its not only children. There are many things happening to adults as well. Increased rates of thyroid cancer, heart attacks, leukemia, cataracts – many, many health problems, where they are wondering theres something definitely wrong.

12ʬν - ϡҤɤãǤʤƱͤͤˤ¿λäƤޤþ⡢¡ȯ¡(ȯ)Ψ- ¿Ρ¿ηꡢΤȤԻ׵Ĥ˻פäƤ...Τ˲ְäƤޤ

At 16:00 — I cant forgive the govt, theyre murderers. This is definitely a holocaust.

16ʬν - ܤȤǤʤϻͼԤϴְ㤤ʤۥȤǤ

At 20:00 — Media wont report on it. Everythings just being swept under the rug.

20ʬν - ǥϤƻޤƤˤ夦βʧ줿(ä줿)

At 26:00 — A TV program called Hodo Stationǡ they went to Fukushima City to interview people and they also came to my clinic The director that made this program also made a follow up show and contacted one of the interviewees telling her, Well be airing it soon. But before it was aired, it was taken off the program. This director died. This director apparently told one of the interviewees, If you do hear that I died, please believe that it was not a suicide, no matter what you might hear. There is no truth in the media in Japan today. There are all sorts of these mysterious events happening that are still unexplained and uninvestigated.

26ʬν - ƻơפȸƤФƥ...Ͽ͡˥󥿥ӥ塼뤿ʡԤ˹ԤޤϻΥ˥åˤ褿...Υץäǥ쥯ϡޤեåץ硼()˸ä󥿥ӥ塼Ԥΰֲͤܿ桹ϤˤǤ뤳ȤǤ礦פϡˡȤߤˤʤäΥǥ쥯˴

Υǥ쥯ˡ󥿥ӥ塼ΰĤǸä֤⤷ʤ䤬ʹʤ顢ϼǤϤʤäȿƲȤʤʹȡ׺ܤΥǥˤϿ¤ޤ󡣤ޤ̤ĴǤ롢ƤμΤδʻΡޤ

At 43:00 — Even today the govt is insisting the rise in pediatric thyroid cancer rates are not due to the accidentWhy are they being so insistent? Its because the moment they admit the reality of whats going on, then they obviously cant restart any of the nuclear plants and must change their entire nuclear policy.

43ʬν -ǤܤϡþȯΨξ徺ϻΤˤΤǤϤʤĥƤ...ʤϤȤƤ⼹ٹ˹ԤΤ餬äƤθ¤ǧ᤿ִ֡θ餫ˡθȯŽƲƯǤʤʤꡢΤѹʤФʤʤʤ롣

CH_SLO

Carole Hisasue, translator (at 1:15:00): Its disappeared from the media, its disappeared from peoples consciousness. Theres this big culture of denial going on outside of Fukushima. They want to pretend like it never happened. I cant talk to my own family about radiation contamination They dont want to hear it. They go, You dont understand because you dont have to live here, we have to live here.ǡ Its like see no evil, hear no evil, speak no evilǡ just trying to ignore it and pretend life is the way it was before 3/11.

롦ԡ115ʬνǡˡϥǥѤäϿ͡ΰռäƤޤʡγ¦˹ԤΤݤȤ礭ʸޤϤ줬äȤʤ褦ʤդ򤷤

ϡǽˤĤƻ伫Ȥβ²äȤǤʤ...Ϥʹʤϸ֤ʤϤ˽ɬפʤΤǡ򤷤Ƥʤ桹ϤƤʤФʤʤ...Ϥ礦ɼٰ򸫤ʤٰʹʤٰäʤΤ褦ʤΤ... ٤̵뤷褦Ȥ褬3/11ͤʤդ򤷤Ƥ롣

Its frightening, its very very frightening [My sister-in-law] is completely brainwashed by the govt who says, Oh no, its fine, fine, fineǡ she believes it, even though her son suffers from a lot of nosebleeds — and I think thats a serious problem. If I mention it to her, or even to my own mother, they get very offended. They go, Oh no, no. Hes always been like that. Its nothing to do with radiation. Talk about denial, it just hurts my heart.

϶Ǥ˶Ǥ... [ελ]ϡ֤䡢פǤפǤפǤסȸܤˤäƴǾƤ... ©ҤɡǶ줷Ǥ뤱ɤ⡢Ϥ򿮤Ƥ롣

ƻϡϿȹͤ롣⤷䤬ˡ뤤ϼʬˤڤ顢˵ʬ򳲤롣ϸ֤䡣(©)ϤĤ⤽Τ褦ˤƤޤϡǽȤϲδطʤǤˤĤäƤȤ˿ˤ롣

Watch video of the event here

Report From Fukushima And The Abe Government Expansion And Export Of Nuclear Plants



ȸ

ɡʱ졢絤ʤɤθǡͤδⴵԿ17500ͤȿ

Τԡ17500ͤȿ ǿĴ

2016ǯ127()1110ʬۿ
 
2016-01-27_201744

AFPǤϡɡʱ졢絤ʤɤǡ󴵼ԿƤȤĴ̤26ȯɽ줿2015ǯΤο430㡢Կ280ͤ˾ȿפȤ

̵BeijingˤˤΩ󥻥󥿡National Cancer CenterˤġWanqing Chen˻Ψ븦बƹ񤬤󶨲ACSȯԤγؽѻCA: A Cancer Journal for CliniciansפȯɽˤȡΤˤ1̤٤Ȥ

ˤȡ137000ͤο͸ͭǤϡ󤬸νˤʤäƤȤȯɽ줿ǿϡ72ꤢϰΤϿ2009ǯ11ǯδ֤˼줿͸6.5ˤǡ˴ŤΤ

ϤΥǡѤơ2015ǯˤ뿻ο4292000ȿפ

ϡˤ뿷㤬12000᤯˾ꡢ7500ͤ̿ȤƤ뤳Ȥȹͤ롣

ˤȡ˺Ǥ¿ߤ줿ϡ٤󡢰ߤ󡢿ƻ󡢴¡IJʤɤäǤ󤬺Ǥ¿ͽοΤ15Ƥ˼¿äΤϡ٤󡢰ߤIJ󡢿ƻʤɤǡ餬󴵼ԤȾƤ

Τ˴ΨϽ⤯͸10166ͤǡλ˴Ψ2ܤä

˴Ψ2006ǯʹߡȽξ㲼Ƥ롣ˤȡ͸ι𲽤ȵ޷äǡˤŪʻԿϡƱ74ƤȤ

ˤ˴3ʬ1᤯ߡ¡ʤ֡ˤʤɤɤ򸶰ȤΤäʱϡˤ˴4ʬ1θȤ줿

ǰ٥ȹͤƤ벰絤ú¾ΥХޥdzѤ˼Ĵˤ벰絤ھαʤɤϡν̱¿δĶȯʪˤ餵Ƥ뤳Ȥ̣פϻŦƤ롣Խ AFPBB News

ȸ ƣС˥塼


εʱ˵ԡ30ǯޤǤǯ200

2015ǯ1009 11:57

img_1bf54251cbb4207c3fb06c4268059df7177243

109 AFPǤϵʱ˵Ԥο2030ǯޤǤǯ200ͤã븫ߤȤθ9ȯɽ줿ο2010ǯ2ܤȤʤ롣¿ο͸ƱǤϡˤͤƤȡϷǰ򼨤Ƥ롣

Ѱػ󥻥åȡThe Lancetˤ˷Ǻܤ줿ʸˤȡߤηȽǤȡ㤤3ͤ1ͤϡʱ줬ǻ˴ǽȤδ֤ǤϵʱԤƤꡢȼԤ⸺ƤȤ

ǤϡΤΤФ̤Τ3ʬ1ʾ夬񤵤Ƥꡢʱ˵ԤοϡΤ6ʬ1롣

ϡǶر줬ʤСʱ˵ǯֻԿϡ2010ǯ100ͤ2030ǯˤ200ͤˡ2050ǯˤ300ͤäפȻŦƤ롣͸14ͤǤ2010ǯεʱϢλԿϡ84͡13ͤä

ʱԤλ˴Ψϡʱи٤ʤͤ٤2ܤȤʤäƤꡢ٤Ǿ´桢¡ȯʤɤΥꥹޤ롣

ϡ4079ФΤʱ줬ǻ˴ͤγϡ1990ǯȾ10󤫤鸽ߤ20ؤ2ܤäȤƤ롣

ޤƱ˷Ǻܤ줿ƥȥ󥿡Atlanta˥꡼ݷ򸦵Emory Global Health InstituteˤΥե꡼ץJeffrey Koplan˻ȥޥ롦ꥯMichael Eriksen˻ΥȤˤȡΤФǤǤʤȤʤ륿Хݤ䤽θ¤ˤƤǤȤ

ֹĤФȡȱʡChinese National Tobacco Corporationˡ٤ϡФ䤫פǶ̤ơܤκ7ʾ󶡤ƤפξƤ롣(c)AFP/Mariette LE ROUX

ȸ AFP BB NEWS



311̺Ҥ͹Ͽ̤Ǥڵ򡡥ʥɡ졼ʼΦ Ť

֥ȥפʼ Ϥʤɤ

img_1

2011ǯ313 浡٥ȡ᤮12᤮20᤮
졼ץ롼ҹԡʡ줫185kmʾεΥ
ƹʤ񡧥졼̤ΰ¬̤ɽ
313ΰ١١ϸɽƤʤ

ִĹϾȰã˿ޤʤ褦ԡ̿ᤷޤʤʤǤϵ߾夲ʬƻȤäƤ뤫Ǥ˼٤ǾȰãϤο򤷤ᤤꤷƤޤ

ּʬƤʤȤܤ˺ǽ餫ݤĤϤ졢ؤۤȤɴ˵錄Ƥʤ̾͡ơ٤ȸޤסʥѡʼ

ΰͤǤ륹ѡʼ⤬ƬˤմʤƤ⡢դϡƬˤʤƿۤʤ衣Ȥϴطʤפˤޤ󡣤Ϥޤǡȸ֤֤¡ɤȸƾΤ롢ǯ֤ʤߤ뤳ȤʤޤĤդԡɤȥåƥŽ줵Ԥο͡ʤȤޤ

̡ȤȤȤƥƥ饤줿Τϡ褦䤯ǯˤʤäƤǤ

Ѵɸܥ˥ɸ
ե˥ȥ饯Ǥξµ

Ȥΰ̴طξϤʤƤޤ󡣸ʳؤǤϡɾȯŤ뤳ȤϤǤƤ⡢θʪǤꤹ뤳Ȥ϶ˤƺǤ

ʳǤޤ;ˤ󤢤ޤե˥䥤饯ǤϡԱʴĶԱʰʪȥ쥹ˤϲʪαƶѴʼˤϲʼкȤѤʤαƶޤǡΤ͡װʣ¸ߤʣƤޤ

ʤΤϡȤ̤⤯ʤȤ⡢ʪǻ뤤ǻ̤ơݼ褷硢ĤޤꡢˤƤϡȤ̤Ǥ⡢ӤС˲ϤǤꡢ˦DNAʬ»˲ǤȤȤǤ

ΤˤȱȿꡢϤ⤢ޤĿͺꡢƱĿͤǤĴѲޤ

˲ϤȤ⡢˦DNAΡɤ̡»뤫ϡζǤĤޤϡΨȤȡդѤСԱȤȤǤ

󡢰شطϤꡢΨŪΤаܤǧǤ礦

ȤǡͤξΥʥɡ졼ξ⡢ɾʤ͡γ礬ȤƤ⤤褦˴ޤ졼ο͡Ʊʾ˿ʾ֤줿ܿͤοΤɤʤΤǤޤ󤬡餯ɴͤΥǤϤʤȻפޤ

ξɾ͡ʤΤǤ礦ȤСƬˤմ餤ʤ顢äȲƤޤäƤΤǤϤʤǤ礦ƤޤäƤΤǤϤʤǤ礦

Ƭˤմ餤ʤ顢ξɾʤƤƤ⡢ɤΤ褦ȿ֤äƤ뤫ƤޤΤǤ礦֤֤¡դԤͤΤǤϤʤȤ졼Ǿɾʤ͡γȡܿͤƱͤξɾʤ͡γȤ;ˤ⤫ΥƤ褦˴ޤ

16534229007_208edc8281_o

16121543083_367de98791_o

16741486955_15f5eef7e2_o

Φγˤ϶ʥɡ졼ʼ311ο̸ϤϻΦǤ

MAP_00

Diseases of the nervous systemand sense organsзϡдﴱ 1
Diseases of the circulatory system ۴ķϼ333
Ƶ۴ 931
ò722
Ǣ247
Diseases of the Male Genitalia 187
Diseases of the infertilityǥ()38
malignant neoplasmʪ46
þ35

ס2540

benign neoplasmʪ158
infectious and parasitic diseases 654

ס812

ƴ2540͡ࡡȰ4843ᡡ52󡡡ǡ2014ǯ6

ȯΤǽʤ顢ʡ縩̱¨ࡢ⤷̤οͤˤʤäƤϤǤԻ׵ĤǤͤʾС ʼΦ˸ųݤˤȤȯ黰Φǹǻ٤ǽӤΤǤϡ

ư2ʬ30նܡʤ椬롪Ƥޤä




Ͽ̤⥢ꥫˤ͹Ͽ̤äøϩ̺Ҥ͹Ͽ̤βǽ⤤

͹Ͽ̡Ͽʼˤʿˤ⤹Ǥ¸ߤƷ29黵줿ɮǽ񤫤줿ӥϿ̤μϲ򤪸񤤤ޤ礦פϡ餫餬տŪ˵͹Ͽ̤Ǥ뤳Ȥǡ¤ʪäƤ롣

131295010157013306518_TS3R0025

fc2_2014-04-25_18-25-52-530

ޤϿȷˤܡʤäȤ⤳ϴ¬ο̸εΥˤ

131294969133413306324_TS3R0027




ɽ̤夷򤤱Ѥ礭ȯʪθƵǻ٤⤯ʤ

α졢ϢḶʪǻٹ⤯

2015ǯ327()1916ʬۿ
 
1cf76c78

ɽ̤夷򤤱Ѥ礭ۤɡȯʪȥǥҥɤθƵǻ٤⤯ʤ뤳Ȥʬäȡرοijضθ楰롼פ27ޤǤȯɽ

롼פβ̻ʰդϡָʤСݤͽɤȾǤǽפäƤ롣

ȥǥҥɤϡФαӥʤɤ˴ޤޤ졢Ǥϥ륳ʬ򤹤ȯ롣ȯ뤳ȤʬäƤꡢƻΤθˤʤȹͤƤ롣

롼פ2087Фη򹯤˽65ͤĴξդݡʤäˡפѤ礭ͤۤɡƵΥȥǥҥǻ٤⤤Ȥʬä

٤ʱ̵ͭȤϴϢʤݤǻ٤뤳ȤǧդϡݤǴĤ䤹ΤǡȤλƳƤۤפդƤӳݤƤ롣

ȸ ̿


塢ꥹȥǥҥɹǻ١ʤɲ

2015/03/27 19:34

ɽ̤ˤǤ򤤱ݡפ¿ͤϡ乢ΤθˤʤȤ벽ʪ֥ȥǥҥɡפθǻ٤⤤Ȥ򲬻̳ƻΥबͤߤᡢȯɽ

ϡݤǻ٤뤳ȤǧƤꡢ򤭤줤ˤ뤳ȤͽɤˤĤʤǽ롢ȤƤ롣

ˤȡݤϡ٤䡢椫ϤǴ˦ٶݤޤäΡ椬礷䤹夷䤹θȤ⤵롣

Ϸ򹯤˽ͤоݤ˼»ܡ

ȸ ̳ƻʹ




Ŷȳμ֤Τʤȥˤ롩ݤɤš

ݤ֤šפμ֡ŶȳͭͤΤʤȥˡ

2015.3.21 17:05

cancer

ԤʤˤʤϤʤΤˡԿƤʤʤꤽΤޤޤǤϡ±˹ԤΤݤʰŤʬˤ롢ΤꤿʤäŤθ¤򸫤ĤΤؤݤš١ʾش۴ˤš󸡿ǡԤ΢¦硹ΤϡشԤ衢Ʈʡ١ʸ麽սˤܤΰųŨ˲󤷤ƣᡣ40ǯ֤ˤ錄ԤȤƳưƤı±ǸƤȤиƤȤʤɤ顢ųο¤λѤ⤭Ħˤ롣

ȤݤѤȹ޼

裱Ϥ裲ϤΤϡŤݤΤ褦ʼ֤ΤСݤʤϺʲͥ¼ϺΤȡˤϡƻμѤ󣴤˴ʤäλϿƻŦѤˤ롣òդ뤷ARDSʵƵ۵ɸˤΤϡѤˤäưߤ䵤ƻεǽ˾㳲򵯤̤ʢ裱19ڡ

줿ƻŦФޤ夲ѿƻѤηֽ̤ѻסïˤǤⵯ뤳ȤˡѤؤ԰¤ΩƤ롣ʤСޤȤСȤ⤤ʤ

ޤʤθϡ˦򻦤Ʊˡ˦򻦤ƤޤȤˤ롣ά˺Ǥ¦̤ϡ̿˴ؤפ¡˳Ϳ뤳Ȥ񡢽۴ĴƵ۴òǢФʤɤεǽ㲼롣η̡Τϰ۾褷ơҤɤʤȻ˴롣ʢ裲43-44ڡ

Ѥ⹳ޤ⿮ʤŤʤΤˤʤäƤΤϡǤϤʤųμˤäѤϡ19˻ϤޤäȤ顢Ťκǿɤεǽȸʤ졢ų˷פƤά˼褬ѤǼѤޤСʸʤɽ񤫤ʤƤ⡢Ĥޤ긦椷ʤƤ⡢ƻΤʤǤ롣άˤäơڽǤϼѤˤʤäơ¡郎Ƥޤʢ裱25ڡ

޼Ťζϡμ¸︳ԡˤˤ뤳Ȥά裲μ¸ФΤϡ⤦򤷤Ƥ⼣븫ߤΤʤԤоݤˤʤΤ󡢰ߤ٤㤬ʤɡȤȹޤʤΤǤ롣ˡǤˤۤιޤȤäƸ̤ʤԤǤ뤫Ǥ롣άˤ븫ߤʤʤ顢Ĥ줿ǤQOLݤʤ顢䤫餷ͤ¿Ԥϡ̤Ĥơ¸ˤƤޤΤʢ裲45-46ڡ

󴵼Ԥϡȼ¸ΤѤȤȤųˤϡ¤˶줷ͤߤȤǰФĤäƤʤΤ˾ʤ롣

ecb1503211705001-p1

󸡿Ǥ˰̣Ϥʤ

Ť⤢̣ǶΤ󸡿Ǥ裳ϤǤϡ󴵼ԤĤФ븽¤򼨤Ԥ򤬤󴵼Ԥ˻ΩƤΤϡŤݤʿʤȤޤ̤äƤ븽¤ˡضڤ롣

󸡿Ǥ˰̣ʤȤϡܤΤˤ˴Ԥä˸ʤ¤򸫤Ф狼롣ϫƯʤפǤϡ˴Ԥ1950ǯʹߡĤŤƤΤǤʹ֥ɥåڤȯšפ侩Ƥ롣ǿɤ褦ˡŤСʹԤˤʤʤΤȤ顢ܤǤ󴵼ԤƤΤˡʤ˴ԤϸʤΤȯ뤬¿֤ɤפǤ뤫ʢ裳74ڡ

֤ɤפȤϡ¾¡žܤƤ餺֤ƤžܤʤΤȡ֤ɤפ򤬤ȤƼ갷Ť˻äƹԤΤϡŤϻȤǤ⤢뤫ְϻѡפȤ¦̤ϪʤޤǤɽФƤ롣

䡢󸡿Ǥ¿οͤ٤Ƥ롣ԤǤʤȯŤ뤳ȤŤ˲ԤȤǤ롣󸡿Ǥ餬Ť˻륳ϡ±礭ʼˤʤꡢԤ俦ܤäƤ롣άˤµˤʤͤοϡǯƱǤ롣Ծ쵬ϤϷޤäƤΤǿʻԾȤơ򹯤ʿͤ¿ͤ˻Ωƾ夲褦Ȥ롣Τμʤά˺򹯤ʿͤŻȤˤȤäƤǤʤΤ餬ʤȰŻȤϲäƤʤʢ裳79-80ڡ

衢ְϿνѡפǤ٤ʤΤȤȤƤ¦̤⤢뤳ȤǤ롣򹯤ʿͤ¿ͤ˻ΩƤΤϺΤΡŵؤФ뿮꤬ΩƤƤ褦ʾ׷롣

ɬפʸŤϼʤ

裱Ϥ裳Ϥϡ⤤ѤŤǤꤿΤȤ򤷤Ƥųΰݤ򶯤ݤŤ裴ϰʹߤϡְäŤ両ǤΩԤ襤˥եȡɤΤ褦襤βãϤ濴ˤʤäƤ롣

襤ˡԤˤ̣Ԥʤɤ餺Ȥ襤򶯤롣ΤѤˡǥѤԤ̣ˤĤ뤳Ȥäʸ麽ս٤ˤʸǺܤȤ̼ͤФƸäȤ襤βʪäƤ롣 ƤԽϤžäƤ뺢ܤϤդ̼ƤӴ󤻤Ƹä֥ѥѤϤ줫鳰ʤ˰狼ޤ롣ǡơϤʤ뤫⤷ʤи礷ƤƤפȡʢ裵 132ڡ

ơ襤̵ǤϺѤޤȼԤʧäϡƻǤ줿Ȥäиᡢǯֻդƻ줿Ԥи᤿ʹ֤϶֤Ȥǯֻ줿֤Ȥäƺǿΰʸɤ߹ߡǥѤƤޤǤΤŤ䤬󸡿Ǥ򿿤øꤹưȯŸ롣οĺȤΤشԤ衢臘ʡ٤Ǥä

򤯤ʤΤøꤵ줿ųʤդ깽鷺Ԥ٤ˤ롣ʰų褽ˡԤԤ̣Ԥγˬ뿷ϸ䤿ʤɥԥ˥ͤ¿Ȥ顢ԤϼŤ򤻤̤륻ɥԥ˥򳫤ųȤ襤ԤɼԤäȤϲϡεҤΤ˼Ƥ롣

ͤϼˤޤ褹Τַ䤫ˡĹǤ롣ɼԤˤϡɬפʸŤʤ褦ˤƤ餤ΤˤϰŤ伣ˡμʳˡŶȳͭͤˤĤΤäƤȤɬפΤʤȥˤΤǤ롣ۤζȼʤ饫줿Ȥǡ⻺򼺤ŤǤϺǰξ硢̿ʤʤ롣ʢ裷 205ڡ

ŤϻȡȸԤ±ˡҤŵҤλǤࡣ͡ʻǤʣʹޤ±θʤˤФˤʤäƤС̿ʤȤäƤ롣ĹСʤ뤷ʤ줬ԤɼԤåǤ롣

ȸ sankeibiz


οͤѤǻ줿ڽ˰ߤ򥰥˰ĥäơѸְ߲㤨ٱˤʤäƻ

Ԥϡ֥ϼϥ󤸤ʤפȸ






ʡ縩ǴˤͤΨ褽6000 ֻҶιþ¡¡ȯפʤɤδԤ

ʡ縩ǡ󴵼Ԥο6000

2015/03/03() 23:37
 
82a8b15465b68743247392afd599a0e9_XL

ʡ縩Υ˥åˤޤȡǿʷ򹯾򤫤Ƥ봵ԤοƤȤȤǤ

ե̿ˤޤȡҶιþ¡¡ȯ¾η򹯾꤬ʡ縩ǹäƤꡢʡ츶ȯŽ˶ᤤϰǡˤͤΨΨ褽6000ȤȤǤ

ǽȤϡʡ츶ȯΤθλ˴ؤäƤ뤳ȤǧƤˤСµϡǤƤʤˡ餫ˤʤäƤʤȤȤǤ

WHOݷ򵡴ؤϡ˻Ƥ͡ФĹ֡դοǻˤ뼣ŤΥץʤ褦Ƥޤ

2013ǯ2ȯɽ줿ǡWHOϡʡ츶ȯΤθ塢ܤι⳰͡ʼΤäͽ¬Ƥޤ

WHOϤˡȯ˺ǤᤤϰǡλҤοˤ70äͽۤޤԤϡλΤĶ͡η򹯤˵ڤܤƶϡǯвᤷʤʬʤȤƤޤ

ȸ iran japanese radio


ʡ礫Ȱθȯ͢

9c3a8cebf7ef4fc3a0d81b2c20910c93

Reports were made on the continuing contamination in Fukushima Japan and the role of the Abe government including action by Doro Mito railway workers who have been ordered to restart rail lines next to Fukushima despite the continuing health and safety dangers.
Chieko Shiina from Fukushima and a supporter of the Fukushima Collaborative Clinic, Isamu Sam Kanno of No Nukes Asia and Chizu Hamada of No Nukes Action spoke at the meeting. The
presentations were translated by Carole Hisasue who is with Mothers For Peace and also reported on the situation in Japan.
This conference took place in San Luis Obispo near the Diablo Canyon. It was called by the Nuclear Free California Network. and was held on January 24 & 25th, 2015
For more information on the Fukushima Collaborative Clinic

Report From Fukushima And The Abe Government Expansion And Export Of Nuclear Plants






˦μȱ֥ƥˤäƾ뤳Ȥ

μŤ˿ʸȱ֥ƥˤäƴ򾮤뤳Ȥ

2014ǯ1129

˦μ礬ʤʤʤʤΤϡȱֵǽˤäƼʤǤȹͤƤȱֺ˦ˤäư˦Ť뤳ȤǤǽǿˤäƼ줿

⤷⤽줬¤ΤΤȤʤС˦򥳥ȥ뤹뤳ȤǽˤʤꡢĹŪʼŤ䡢֤̿ǽˤʤȸƤ롣

̾T˦CTLA4PD-1Ȥäȱֺ˦ˤä̵ƤޤΤ빳ΤѤ뤳ȤˤäơCTLA4PD-1֥åT˦˼򹶷⤵뤳Ȥ

""ȤդȤ褦ʤȤǤϤʤˤ衢ĹŪµδ֤̿ȤƤϽʬʲǽȸԤϸäƤ롣

ȱ֤ˤ뼣ˡϡޤΤˤ̤Ƥ餺ԤϲͳȤʤäƸ̤봵ԤȤǤʤԤΤˤĤơ³Ĵ³븫ߤǤ롣

ˤ衢ȱ֥ƥब˦ŨȤߤʤȤǤȤΤ礭ȯǤꡢοŸǤϡˤ϶뤳ȤΤʤ¤ˤʤ뤫⤷ʤ

ȸ ˥塼

˦ⲽȤߡ

cancerous_change_02


Multiple boosts for cancer immunotherapy

26 November 2014 3:30 pm

sn-immunotherapyH

Tumors persist and grow in part because they squelch the immune system, but researchers have recently turned the tables with treatments that prompt immune cells to hunt down malignant cells. The strategy is effective only in some patients, however, and so far has been shown to work in just a few cancer types. But studies online today in Nature reveal how one kind of immunotherapy, so-called immune checkpoint inhibitors, can be targeted to new cancers—and how doctors can single out the patients who are most likely to benefit from these drugs.

As a unit, these papers fill out many of the gaps in our understanding about these cancer immunotherapies, says Jedd Wolchok, a medical oncologist at Memorial Sloan Kettering Cancer Center in New York City who wasnt connected to the studies.

Tumors can suppress the cytotoxic T cells that would normally attack them by activating two immune cell surface receptors , CTLA4 and PD-1. But blocking CTLA4 and PD-1 with antibodies can unleash the T cells. Several clinical trials of patients with incurable cancers have shown dramatic effects from these antibodies. What we are seeing is long-term disease control, Wolchok says. In some cases, people are living long enough to die from another cause.

Researchers shy away from the c-word—cure—but they say that these immune checkpoint inhibitors could ultimately transform cancer into a manageable disease more like diabetes or HIV infection. The immune system may be able to keep the tumor in check, even if it doesnt eliminate every last cell, says cancer immunologist Drew Pardoll of Johns Hopkins University School of Medicine in Baltimore, Maryland. Prospects like that led Science to anoint cancer immunotherapy as its Breakthrough of the Year for 2013.

Yet so far, published studies have confirmed that the checkpoint inhibitors work only in kidney cancer, melanoma, and lung cancer. And even in those cancers, usually less than half of patients benefit.

In one of the new studies, a team led by oncologist Thomas Powles of Queen Mary University of London tested a new antibody created by Genentech of South San Francisco, California, in a different cancer: a difficult-to-treat form of bladder cancer. Instead of blocking PD-1 on immune cells, the antibody disables PD-L1, a protein that cancer cells and some other cells display to stimulate PD-1 and inhibit T cells. The Genentech-funded study found that the antibody shrank bladder tumors in 26% of the patients. Therapy for this type of cancer has not advanced in 25 years, notes Hopkins medical oncologist Julie Brahmer, who wasnt connected to the research. This is truly groundbreaking, she says.

In a second study, also funded by Genentech, translational oncologist Roy Herbst of the Yale School of Medicine and colleagues tested the antibody against several other kinds of incurable cancers. The patients in this trial had exhausted one, two, three lines of treatment, Herbst says, but he and his colleagues found that the antibody caused tumors to shrink in lung cancer, head and neck cancer, melanoma, and other tumor types. It is unexpected and exciting to see a single drug having an impact on so many kinds of cancer, says Suzanne Topalian, a cancer immunologist at Hopkins who didnt take part in any of the studies.

Still, fewer than 20% of the patients in the Yale trial saw their tumors dwindle. Its a big conundrum to predict who will benefit from these treatments, Herbst says. When he and his colleagues analyzed tumors from the trials patients, they found a potential explanation: variation in the amount of PD-L1 manufactured not by the cancer cells, but rather by the immune cells that had invaded the tumor. (The cancer cells may somehow compel immune cells to make the self-inhibiting molecules.) If these invading cells produced plenty of the protein, patients were more likely to respond to the antibody therapy. Testing PD-L1 levels in patients tumors might enable doctors to identify the people with the best chance of benefiting from the new antibody, Herbst says.

In a third Nature study, tumor immunologist and physician Antoni Ribas of the University of California, Los Angeles, and colleagues pinpointed another biomarker that might help improve the success rate of the immune-awakening antibodies. After poring over biopsy samples from the melanoma tumors of 46 clinical trial participants treated with a PD-1–blocking antibody, the researchers found that the best portent of treatment success was the abundance of cytotoxic T cells at the edge of the tumors. The more cells crowding into the edge of the tumor, the better.

To confirm their finding and gauge its usefulness, Ribas and colleagues then analyzed biopsy samples from melanoma patients in a clinical trial at another hospital. Using just this one feature, they correctly predicted how well 13 of the 15 patients would respond to the antibody therapy. An assay that detects the presence of [cytotoxic T] cells in tumors could be the first decision point in the treatment of patients, Ribas says.

Researchers are already looking at how to use the results of these studies to improve cancer immunotherapy, possibly by combining it with other types of treatments. The next use will be in combination with other cancer drugs to get a greater impact, Topalian says. 

Posted in Biology, Health

ȸ Science

ե󡪥ץβݼϴˤʤȤ

ץݼ衢ȯ¥ ե

2014.08.14
 
20121009_42768

οٲ᤮Ϥˤʤ!?

餻뤫ס֥åȸ̤뤫פȤäơʤɤδڹФФ٤ƤͤϡդäƤɻҡƥåȤˤĤʤȸƤ륫ץݼˡȯꥹ뤳ȤȽ

Υå󥰤ʸ̤ȯɽΤϡ廳±Υࡦۥ󥷥ࡣ

ץΤȯϤʤΤץ̤ݼ褹ȡʥ륭顼˦еǽ㳲ơȯ¥ʤȤʥ륭顼˦ϡ˦व빳ȱֺ˦

äȤοɤʤס

Ϥ˦оݤˡץ10M20M50M100Mʥޥˤ̤Ϳʥ륭顼˦ץͿ32äΤ50MͿ16ˡ100MͿ4ؤ˲

ץ50Mϡ̾1ℓɻ150g15١ˤ줿̤ܤǿ٤Ǥ褯ʬ̤

ʤߤ˥ץ10M20MͿǤϡʥ륭顼˦γ2827ǤꡢͿ32纹ʤäŬ٤̤Ǥȯꥹʤ櫓

θ̤ɻҤȤڹǤ礭ʾ׷ͿƤ롣ޤǤ夷ƤܤǤդɬפʤΤϴְ㤤ʤ󡢽뤤˿ɤο٤ƥӡäơǹʤǤɤۤ͡ɤۤɤˤȤȤʤǤ礦

ʸܾ

ȸ
⤰⤰˥塼



06374-top

ȯȤΥɥ澾Ω ;̿2ǯפ

ɥ澾;̿2ǯפ

2014/06/26 18:56

mqdefault (3)

ȯȤΥɥ澾Ω𤵤줿ȯɽޤ

ɥ澾󡧡֡夫ˡΤǯǯޤǡ٤ȸޤ

澾26夫鵭Բ񸫤Ԥǯ12դΩȿǤ졢;̿2ǯ𤵤줿ȤȤǤ

澾ϡοʼˡȯʤɤ˼ȤߤȤƤޤ澾2λ˽Ϥ64000ɼ;Τޤ

ȸ
ƥī˥塼



γưϴͽɤϤᡢ̿Фդ

Ȼ򤹤Ǥͽɤˤʤ

2012.9.24 MON

2401375241_9144ddf7eb_b

ˤĤƹԤ줿븦ˤäơβȻΥꥹ13󸺾뤳Ȥ줿ˤ̤롣

γưϤͽɤϤᡢ̿Ф錄դ롣븦椬γưβäˤϡȻ򤹤뤳ȤǽʬǤꡢȯãꥹ13⸺餹Ȥ򼨤
 
ŻȤݽλ⡢֤ʤɤϡ䥸祮󥰤ȤޤäƱ褦˵ǽư
 
ϡEPICEuropean Prospective Investigation of Cancer: 衼åѡͽĴˤˤäƹԤ졢International Journal of Cancerפ˷Ǻܤ줿äˡꥢǽ10ͤ1ͤͻƤ롣ϡ˺Ǥ¿ǡ뤹٤ƤΤ25ᡢλ˴ȤʤäƤꡢ礬˴ʤ뤦Ρ17γƤ롣
 
8,000ͤνʬϤơưŪ򤷤Ƥ뤫ƤʤʬषưŪ򤷤ƤϤ򴵤Ψ13㤫ä٤˳ưŪפȸʤ줿Ǥ⡢8Υꥹ줿
 
̣Τϡγưβäˤϡ鷺ʳưǽʬȤȤֱư򤹤ȤΤϡǤ©夬뤢뤳Ȥ̣ƤޤɬϫưǤʤƤ褯ơݽꡢ륬饹򤭤줤˿Ǥ⽽ʬʤΤǤפȥꥹꥵΥ顦ҥƤ롣
 
ֽäơ򹯤Ѳ⤿餹ˤϡ錄ν򾯤ѤǤ褤ȵŤȤפǤ˳ʤ롣롼ȤΰʬǤ⤤顢⤤ƻŻˡعˡ㤤ʪ˹ԤפˡȻϤȤơDzǽʸ¤ΤưȤФΤǤסΤȤʤ顢ͭʤΤϽǤϤʤ
 
ȽˤĤƹԤ줿̤θϡݡġषγưϡ1ǯ3,000Υ򸺤餹ȤǤ뤳Ȥ򼨤Ƥ롣Ūʥɥ饤ϡ1֤˾ʤȤ150ʬĤޤ2Ⱦαư򴫤Ƥ롣39Ƚ29󤷤Υɥ˽äƤʤ
 
֤ΤᡢưŪǤȤȤϡФޥ饽򤹤뤳ȤǤϤʤΤ뤳ȤפȤʤޤкŪ;͵ѤǤ뼫ͳ֤ٳ뤹ȤƤ⡢錄Ϥ줾줬ΰȤƱưϤ뤳ȤǤޤ鷺ϫϤǡ礭ʲäΤǤ

TEXT BY MICHELA DELLAMICO
TRANSLATION BY TAKESHI OTOSHI

WIRED NEWS ʸ(Italian)


ȸ
wired


ޥեʤϴμ˦򻦤˸ø

ޥեʤϤݤø!?

2012.9.26 20:36
 
wir12092620370005-p1

ޥեʤϤμ˦򻦤˸ˡΤ褦˲ŪѤ⤿餵ʤ椬ޥեʤ˴ޤޤ륫ʥӥǥTHCͭ΢դ

Ԥδ֤Ǥϡޥեʤ¸ߤ륫ʥӥǥCBDˤȤʪ˦Ĺ٤餻Ƥ˦η˸뤿ᡢ䤽žܤƮΤΩĤȤοޤäƤ롣ͭ΢դ뿷椬Τʪˤߤ䡢Ǥ䡢µ䲽ˡѤ¤뤳ȤϤǤΤƤ롣

Newsweek٤Ƥ褦ˡǤ2007ǯ˥ե˥ѥեåť󥿡Τ븦椬ʥӥǥ뤬󴵼Ԥμ˦ɤΤ褦˻˲ơµۤκ˦žܤ뤦ǸȤʤ̤ѥID-1ҤΥå򥪥դˤ뤫򼨤Ƥ

ΰҤϡ򹯤ʸΤˤƤϡȯδ֤Τ߳ư롣䡢¾οʹԤˤäͤˤƤϡΰҤươµΤۤη򹯤ʺ˦ؤΰܹԤơžܤȤѻ줿

֤ΰҤ빶Ūʼ10ޤ¸ߤפȡԤƤ롣ơʥӥǥϤߤ뤳ȤǤ롣äơΤʤϤʼˡȤʤ롣ˡΤ褦µߤ뤱ɡ뤢κ˦򻦤¿ͤΤ˲벽ˡȰäơΰ˦Τߤ֥å뤳ȤǤΤ

֥ʥӥǥϲͤδԤˡŤδ˾Ϳפȡ楰롼פΥ꡼̳᤿ԡޥꥹϽҤ٤衢漼Ǵѻ줿̤ΤǸڤ뤿ɬפ׾ϤޤԤƤʤ

ޥꥹϤޤ󴵼Ԥˤμˡθ̤ƥȤ뤿λõƤ롣δθ楰롼פϡ漼ǥʥӥǥܤˤˡ򲽳ˡȤ߹碌뤳ȤǽͭפɤʬϤƤ롣θϡʥӥǥθ̤Τ褦ˤƶ뤳Ȥ򤹤Ǥ˾ѤߤƲˡϤ궯Ϥʸ̤ߡդϾʤʤ롣ȤΤ⡢̤Ū˸餹Ȥǽ

ʪθ̤ȯΤϡޥɥ꡼ɤΥץƥؤʪؼԡꥹƥʡǾμ˦ʬϤ뤳Ȥǡ˦οդ򸦵椷Ƥ̤κ˦⤺ä®Ĺ롣ϡκ˦ƥȥҥɥʥӥΡ˻ȤĤǤ뤳Ȥ˶դޥեʤθѤͭ̾THCΤȤ

ϸ³1998ǯˤȯɽơTHCǾΤȤ櫓Ūʷ֤ĺ˦ΥݥȡʤͶȯ뤳Ȥ³ơ¿΢դޤޤʹǹԤ줿THC䤽¾ΥޥեʤʪᥫʥӥΥɤϡľŪʹ̤äƤ뤳Ȥ狼äƤ롣

ʹ֤Фǽ׾2006ǯ˥ڥǹԤ줿ԤTHCŪʼˡϲäʤä9ͤǾ紵ԤͿơƥľܡµˤä˦THC9ˤƼषȤѻ졢η̤ϡNature٤˷Ǻܤ줿

δ֤ˡϡؤθԤϡ٤ФƤƱ̤뤳Ȥȯ餬ܤǤä٤ȤϡTHC˦ΤߤǷͿ򹯤ʺ˦⤵뤳ȤϤʤäȤ¤

θ塢ɥΥȡ硼ؤκǶθϡ¤ФƤƱ̤׾ˤäƴѻǯ7ɥĤΥե饤֥륯ǹԤ줿ǶιݥʥӥΥɸǤϡΥơޤκǤͭ̾ȤҤȤĤΥơ֥Ϥ

˶̣׸ꥢθԤ⤢ꡢϥʥӥΥɤΩˤ˦νΤѤǤǤ⶯ϤפɾޤꥹΥ󥫥ؤθԤϡIJμ˴ؤƤƱͤη𤷤

餹٤ƤϡȤ襤ˤƿͭ˾ƻڤ򳫤ϤääƤͤФʤʤΤϡѤĥɥåȸʤƤ륫ʥӥΡְŪʡ׻ѤˤŪʪŪʱƶϡľŪ˸ʪݼ褹뤳ȤˤʤǤʤǮʬ򡢤ʤ洬ΡХפdzƤβ߽Ф뤽¾ʪˤ붼Ҥ˻뤳ȤˤĤʤȤȤ

ºݡޥեʤϥդȤȯϡǡúǡʪ˥ȥߥޤǤ롣ޤͷγҾʪϡեΡ롢쥾롢Ƥޤޤ˧²úǡŪȯʪޤǤ롣

ȸ
WIRED








Ǻʤ򼺤ä60ΥʥƼä4220ʥɥ42ߡˤ򡢴μŤȸԤĤ۴

ʤ򥬥Ǽäˡ޶42

2014.01.05
 
a

ǯäϤɤʻȤ򤷤ǡִò᤮פȤơξ޶λȤӤˤʤäƤ롣

ǯǺʤ򼺤ä60Υʥǯ1216Ƽä4220ʥɥ42ߡˤξ޶⤹٤Ƥ򡢥μŤȸԤĤ˴դ뤳ȤȽƤ롣ϥȥࡦꥹȤ64ˡŵ¤ҤθCEOǡǯ9˰षƤ롣ޤƱǯ2ˡ33ǯϢźä׿ͤ򥬥˴Ƥ

ꥹȤϺǯ53äȤ4220ߤξ޶ˤ빬Ĥ⡢ïˤλ¤Τ餻ˡȥ臘εءɤ˴դ򤹤뤳Ȥ᤿ǥμФơּʬϻҶΤˤ⽼ʬʻ񻺤ۤƤ롣⤬ʤƤʤ麤뤳ȤϤʤΤǡפȸäƤ롣

񻺲ȤäꥹȤǤΤȤιʿˤΤʤΤSNSʤɤǤ͡ʰոӸäƤ롣

ʸԽ

ȸ
⤰⤰˥塼







QR
QR
  • 饤֥ɥ֥